Overview
Clinical Meaning
Major depressive disorder (MDD) involves dysregulation of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) in prefrontal cortex, hippocampus, and limbic structu...
FNP
FNP
Major depressive disorder (MDD) involves dysregulation of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) in prefrontal cortex, hippocampus, and limbic structures. The monoamine hypothesis posits that depression results from deficient serotonergic and noradrenergic transmission, though current understanding encompasses neuroplasticity deficits, hypothalamic-pituitary-adrenal (HPA) axis hyperactivity with chronic cortisol elevation, neuroinflammation, and reduced brain-derived neurotrophic factor (BDNF). Chronic stress-induced cortisol elevation causes hippocampal atrophy and prefrontal cortex hypofunction. Generalized anxiety disorder (GAD) involves excessive activation of the amygdala fear circuits with insufficient prefrontal cortical inhibition. GABA (inhibitory) and glutamate (excitatory) imbalance contributes to the hyperarousal state. SSRIs increase serotonin availability by blocking presynaptic reuptake, but clinical effect takes 4-6 weeks due to required downstream neuroplastic changes including BDNF upregulation and hippocampal neurogenesis.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this FNP pathway. You can still explore topic-filtered questions from the bank hubs below.